Drew Deniger
Overview
Drew Deniger received an average of $789K in total compensation, including $332K in salary, at ZIOPHARM Oncology between 2022 and 2023.
Source: SEC filings on April 26, 2024 and April 25, 2023.
Related executives
We found ten more executives who work or worked at ZIOPHARM Oncology.
Kevin Boyle
ZIOPHARM Oncology
Chief Executive Officer
Melinda Lackey
ZIOPHARM Oncology
SVP, Legal & Administration
Jonathan Lewis
ZIOPHARM Oncology
Chief Executive Officer
Caesar Belbel
ZIOPHARM Oncology
Chief Legal Officer
Hagop Youssoufian
ZIOPHARM Oncology
Chief Medical Officer
Jason Amello
ZIOPHARM Oncology
Chief Financial Officer
Kevin Lafond
ZIOPHARM Oncology
Chief Accounting Officer
Richard Bagley
ZIOPHARM Oncology